ZEJULA
- Product NDC
- 0173-0909
- 11-digit product format
- 001730909
- Labeler code
- 0173
- Product ID
- 0173-0909_93e60116-b3f2-4568-ae12-03d6e016a953
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- niraparib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA214876
- Marketing category
- NDA
- Marketing start
- 2023-06-27
- Substance
- NIRAPARIB TOSYLATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ZEJULA
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NIRAPARIB TOSYLATE | 100 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 195Q483UZD |
| Rxcui | 2637449, 2637452, 2637465, 2640210, 2640212, 2640214 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8f213b7a-23f6-497c-a54d-8a37f1798781 | Product name | 1 | 20231023 |
| 595c26ad-ded5-4c95-8cbc-96d487123743 | Product name | 1 | 20231010 |
| 98474c8b-00f8-4165-be9e-bc8fe5ad84d0 | Product name | 1 | 20170608 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0173-0909-13 | ZEJULA | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0173-0909-13 | EA - Each | 0173-0909 | 252c0a2d-b520-426d-a178-92937538ab61 | 1 | 2023-07-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2637449 | niraparib 100 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637452 | niraparib 200 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637465 | niraparib 300 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640210 | Zejula 100 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640212 | Zejula 200 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640214 | Zejula 300 MG Oral Tablet | PSN | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640210 | niraparib 100 MG Oral Tablet [Zejula] | SBD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640212 | niraparib 200 MG Oral Tablet [Zejula] | SBD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640214 | niraparib 300 MG Oral Tablet [Zejula] | SBD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637449 | niraparib 100 MG Oral Tablet | SCD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637452 | niraparib 200 MG Oral Tablet | SCD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637465 | niraparib 300 MG Oral Tablet | SCD | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637449 | niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637452 | niraparib 200 MG (as niraparib tosylate monohydrate 318.7 MG) Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2637465 | niraparib 300 MG (as niraparib tosylate monohydrate 478 MG) Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640210 | Zejula 100 MG Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640212 | Zejula 200 MG Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
| 2640214 | Zejula 300 MG Oral Tablet | SY | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 9 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 0173-0909-13 | 00173090913 | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0909-13) | 2023-06-27 | No | No | Current |